nodes	percent_of_prediction	percent_of_DWPC	metapath
Zafirlukast—ABCG2—epilepsy syndrome	0.13	0.422	CbGaD
Zafirlukast—CYP2C19—epilepsy syndrome	0.102	0.332	CbGaD
Zafirlukast—CYP2D6—epilepsy syndrome	0.0755	0.246	CbGaD
Zafirlukast—CYP2E1—Felbamate—epilepsy syndrome	0.0184	0.0381	CbGbCtD
Zafirlukast—CYP2E1—Trimethadione—epilepsy syndrome	0.0184	0.0381	CbGbCtD
Zafirlukast—CYP2E1—Clonazepam—epilepsy syndrome	0.0156	0.0324	CbGbCtD
Zafirlukast—CYP2C8—Trimethadione—epilepsy syndrome	0.0138	0.0285	CbGbCtD
Zafirlukast—CYP2C8—Fosphenytoin—epilepsy syndrome	0.0129	0.0268	CbGbCtD
Zafirlukast—CYP2E1—Rufinamide—epilepsy syndrome	0.0128	0.0264	CbGbCtD
Zafirlukast—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.0124	0.0257	CbGbCtD
Zafirlukast—PTGS1—Diazepam—epilepsy syndrome	0.0122	0.0252	CbGbCtD
Zafirlukast—CYP2C19—Trimethadione—epilepsy syndrome	0.0115	0.0239	CbGbCtD
Zafirlukast—CYP2C19—Felbamate—epilepsy syndrome	0.0115	0.0239	CbGbCtD
Zafirlukast—CYP2C19—Fosphenytoin—epilepsy syndrome	0.0108	0.0224	CbGbCtD
Zafirlukast—CYP2E1—Propofol—epilepsy syndrome	0.0104	0.0215	CbGbCtD
Zafirlukast—CYP2E1—Phenobarbital—epilepsy syndrome	0.00994	0.0206	CbGbCtD
Zafirlukast—CYP2E1—Midazolam—epilepsy syndrome	0.0098	0.0203	CbGbCtD
Zafirlukast—PTGS1—Valproic Acid—epilepsy syndrome	0.00962	0.0199	CbGbCtD
Zafirlukast—CYP2C9—Trimethadione—epilepsy syndrome	0.00959	0.0198	CbGbCtD
Zafirlukast—CYP2E1—Diazepam—epilepsy syndrome	0.00942	0.0195	CbGbCtD
Zafirlukast—CYP2C19—Clobazam—epilepsy syndrome	0.0094	0.0195	CbGbCtD
Zafirlukast—CYP2C8—Carbamazepine—epilepsy syndrome	0.00929	0.0192	CbGbCtD
Zafirlukast—CYP2C9—Fosphenytoin—epilepsy syndrome	0.00902	0.0187	CbGbCtD
Zafirlukast—CYP2C8—Primidone—epilepsy syndrome	0.00867	0.0179	CbGbCtD
Zafirlukast—CYP2C8—Phenytoin—epilepsy syndrome	0.00833	0.0172	CbGbCtD
Zafirlukast—CYP2C19—Carbamazepine—epilepsy syndrome	0.00779	0.0161	CbGbCtD
Zafirlukast—CYP2C8—Propofol—epilepsy syndrome	0.00777	0.0161	CbGbCtD
Zafirlukast—CYP2C8—Phenobarbital—epilepsy syndrome	0.00743	0.0154	CbGbCtD
Zafirlukast—CYP2C19—Primidone—epilepsy syndrome	0.00727	0.0151	CbGbCtD
Zafirlukast—CYP1A2—Carbamazepine—epilepsy syndrome	0.00719	0.0149	CbGbCtD
Zafirlukast—CYP2C8—Diazepam—epilepsy syndrome	0.00704	0.0146	CbGbCtD
Zafirlukast—CYP2C19—Phenytoin—epilepsy syndrome	0.00699	0.0145	CbGbCtD
Zafirlukast—CYP1A2—Primidone—epilepsy syndrome	0.00671	0.0139	CbGbCtD
Zafirlukast—CYP2C19—Propofol—epilepsy syndrome	0.00652	0.0135	CbGbCtD
Zafirlukast—CYP2C9—Carbamazepine—epilepsy syndrome	0.00648	0.0134	CbGbCtD
Zafirlukast—CYP2C19—Phenobarbital—epilepsy syndrome	0.00623	0.0129	CbGbCtD
Zafirlukast—CYP2C9—Primidone—epilepsy syndrome	0.00605	0.0125	CbGbCtD
Zafirlukast—CYP1A2—Propofol—epilepsy syndrome	0.00601	0.0124	CbGbCtD
Zafirlukast—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.006	0.0124	CbGbCtD
Zafirlukast—CYP2C19—Diazepam—epilepsy syndrome	0.00591	0.0122	CbGbCtD
Zafirlukast—CYP2C9—Phenytoin—epilepsy syndrome	0.00581	0.012	CbGbCtD
Zafirlukast—CYP2C19—Zonisamide—epilepsy syndrome	0.00576	0.0119	CbGbCtD
Zafirlukast—CYP1A2—Phenobarbital—epilepsy syndrome	0.00575	0.0119	CbGbCtD
Zafirlukast—CYP3A4—Trimethadione—epilepsy syndrome	0.00558	0.0115	CbGbCtD
Zafirlukast—CYP3A4—Felbamate—epilepsy syndrome	0.00558	0.0115	CbGbCtD
Zafirlukast—CYP2C8—Valproic Acid—epilepsy syndrome	0.00555	0.0115	CbGbCtD
Zafirlukast—CYP1A2—Diazepam—epilepsy syndrome	0.00545	0.0113	CbGbCtD
Zafirlukast—CYP2C9—Propofol—epilepsy syndrome	0.00542	0.0112	CbGbCtD
Zafirlukast—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00524	0.0108	CbGbCtD
Zafirlukast—CYP2C9—Phenobarbital—epilepsy syndrome	0.00518	0.0107	CbGbCtD
Zafirlukast—CYP2D6—Propofol—epilepsy syndrome	0.00496	0.0103	CbGbCtD
Zafirlukast—CYP2C9—Diazepam—epilepsy syndrome	0.00491	0.0102	CbGbCtD
Zafirlukast—CYP3A4—Clonazepam—epilepsy syndrome	0.00474	0.00981	CbGbCtD
Zafirlukast—CYP2C19—Valproic Acid—epilepsy syndrome	0.00466	0.00963	CbGbCtD
Zafirlukast—CYP3A4—Clobazam—epilepsy syndrome	0.00455	0.00941	CbGbCtD
Zafirlukast—CYP1A2—Valproic Acid—epilepsy syndrome	0.0043	0.00889	CbGbCtD
Zafirlukast—CYP2C19—Topiramate—epilepsy syndrome	0.0042	0.00869	CbGbCtD
Zafirlukast—CYP2C9—Valproic Acid—epilepsy syndrome	0.00387	0.00801	CbGbCtD
Zafirlukast—CYP3A4—Rufinamide—epilepsy syndrome	0.00387	0.008	CbGbCtD
Zafirlukast—CYP3A4—Carbamazepine—epilepsy syndrome	0.00377	0.00779	CbGbCtD
Zafirlukast—CYP3A4—Primidone—epilepsy syndrome	0.00352	0.00728	CbGbCtD
Zafirlukast—CYP3A4—Phenytoin—epilepsy syndrome	0.00338	0.00699	CbGbCtD
Zafirlukast—CYP3A4—Propofol—epilepsy syndrome	0.00315	0.00652	CbGbCtD
Zafirlukast—CYP3A4—Phenobarbital—epilepsy syndrome	0.00301	0.00623	CbGbCtD
Zafirlukast—CYP3A4—Acetazolamide—epilepsy syndrome	0.00301	0.00623	CbGbCtD
Zafirlukast—CYP3A4—Midazolam—epilepsy syndrome	0.00297	0.00614	CbGbCtD
Zafirlukast—CYP3A4—Diazepam—epilepsy syndrome	0.00285	0.00591	CbGbCtD
Zafirlukast—CYP3A4—Zonisamide—epilepsy syndrome	0.00279	0.00577	CbGbCtD
Zafirlukast—CYP3A4—Valproic Acid—epilepsy syndrome	0.00225	0.00466	CbGbCtD
Zafirlukast—CYP3A4—Topiramate—epilepsy syndrome	0.00203	0.0042	CbGbCtD
Zafirlukast—Glyburide—SLCO1A2—epilepsy syndrome	0.000526	0.212	CrCbGaD
Zafirlukast—Glyburide—KCNJ11—epilepsy syndrome	0.000466	0.187	CrCbGaD
Zafirlukast—Encainide—CYP2D6—epilepsy syndrome	0.00035	0.141	CrCbGaD
Zafirlukast—Tolvaptan—ABCB1—epilepsy syndrome	0.000307	0.123	CrCbGaD
Zafirlukast—Glyburide—ABCC2—epilepsy syndrome	0.000252	0.101	CrCbGaD
Zafirlukast—Glyburide—ABCG2—epilepsy syndrome	0.000223	0.0894	CrCbGaD
Zafirlukast—Glyburide—CYP2C19—epilepsy syndrome	0.000175	0.0703	CrCbGaD
Zafirlukast—Glyburide—ALB—epilepsy syndrome	9.71e-05	0.039	CrCbGaD
Zafirlukast—Glyburide—ABCB1—epilepsy syndrome	9.26e-05	0.0372	CrCbGaD
Zafirlukast—Pruritus—Vigabatrin—epilepsy syndrome	9.14e-05	0.00068	CcSEcCtD
Zafirlukast—Asthenia—Diazepam—epilepsy syndrome	9.12e-05	0.000679	CcSEcCtD
Zafirlukast—Body temperature increased—Phenytoin—epilepsy syndrome	9.12e-05	0.000679	CcSEcCtD
Zafirlukast—Urticaria—Oxcarbazepine—epilepsy syndrome	9.11e-05	0.000678	CcSEcCtD
Zafirlukast—Pain—Lamotrigine—epilepsy syndrome	9.1e-05	0.000677	CcSEcCtD
Zafirlukast—Nausea—Acetazolamide—epilepsy syndrome	9.09e-05	0.000676	CcSEcCtD
Zafirlukast—Dizziness—Levetiracetam—epilepsy syndrome	9.08e-05	0.000676	CcSEcCtD
Zafirlukast—Feeling abnormal—Carbamazepine—epilepsy syndrome	9.07e-05	0.000675	CcSEcCtD
Zafirlukast—Abdominal pain—Oxcarbazepine—epilepsy syndrome	9.07e-05	0.000675	CcSEcCtD
Zafirlukast—Body temperature increased—Oxcarbazepine—epilepsy syndrome	9.07e-05	0.000675	CcSEcCtD
Zafirlukast—Diarrhoea—Fosphenytoin—epilepsy syndrome	9.07e-05	0.000675	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Topiramate—epilepsy syndrome	9.06e-05	0.000674	CcSEcCtD
Zafirlukast—Back pain—Pregabalin—epilepsy syndrome	9.06e-05	0.000674	CcSEcCtD
Zafirlukast—Vomiting—Propofol—epilepsy syndrome	9.04e-05	0.000672	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Carbamazepine—epilepsy syndrome	9e-05	0.00067	CcSEcCtD
Zafirlukast—Pruritus—Diazepam—epilepsy syndrome	9e-05	0.00067	CcSEcCtD
Zafirlukast—Rash—Propofol—epilepsy syndrome	8.96e-05	0.000667	CcSEcCtD
Zafirlukast—Dermatitis—Propofol—epilepsy syndrome	8.95e-05	0.000666	CcSEcCtD
Zafirlukast—Headache—Propofol—epilepsy syndrome	8.9e-05	0.000663	CcSEcCtD
Zafirlukast—Hypersensitivity—Zonisamide—epilepsy syndrome	8.88e-05	0.000661	CcSEcCtD
Zafirlukast—Vomiting—Midazolam—epilepsy syndrome	8.84e-05	0.000658	CcSEcCtD
Zafirlukast—Diarrhoea—Vigabatrin—epilepsy syndrome	8.84e-05	0.000658	CcSEcCtD
Zafirlukast—Asthenia—Felbamate—epilepsy syndrome	8.83e-05	0.000657	CcSEcCtD
Zafirlukast—Myalgia—Valproic Acid—epilepsy syndrome	8.82e-05	0.000656	CcSEcCtD
Zafirlukast—Arthralgia—Valproic Acid—epilepsy syndrome	8.82e-05	0.000656	CcSEcCtD
Zafirlukast—Feeling abnormal—Lamotrigine—epilepsy syndrome	8.77e-05	0.000653	CcSEcCtD
Zafirlukast—Rash—Midazolam—epilepsy syndrome	8.77e-05	0.000652	CcSEcCtD
Zafirlukast—Dizziness—Fosphenytoin—epilepsy syndrome	8.76e-05	0.000652	CcSEcCtD
Zafirlukast—Dermatitis—Midazolam—epilepsy syndrome	8.76e-05	0.000652	CcSEcCtD
Zafirlukast—Urticaria—Carbamazepine—epilepsy syndrome	8.75e-05	0.000651	CcSEcCtD
Zafirlukast—Vomiting—Levetiracetam—epilepsy syndrome	8.73e-05	0.00065	CcSEcCtD
Zafirlukast—Discomfort—Valproic Acid—epilepsy syndrome	8.71e-05	0.000649	CcSEcCtD
Zafirlukast—Headache—Midazolam—epilepsy syndrome	8.71e-05	0.000648	CcSEcCtD
Zafirlukast—Pruritus—Felbamate—epilepsy syndrome	8.71e-05	0.000648	CcSEcCtD
Zafirlukast—Abdominal pain—Carbamazepine—epilepsy syndrome	8.7e-05	0.000648	CcSEcCtD
Zafirlukast—Body temperature increased—Carbamazepine—epilepsy syndrome	8.7e-05	0.000648	CcSEcCtD
Zafirlukast—Diarrhoea—Diazepam—epilepsy syndrome	8.7e-05	0.000648	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	8.7e-05	0.000648	CcSEcCtD
Zafirlukast—Ill-defined disorder—Pregabalin—epilepsy syndrome	8.69e-05	0.000647	CcSEcCtD
Zafirlukast—Sinusitis—Topiramate—epilepsy syndrome	8.67e-05	0.000646	CcSEcCtD
Zafirlukast—Rash—Levetiracetam—epilepsy syndrome	8.66e-05	0.000644	CcSEcCtD
Zafirlukast—Dermatitis—Levetiracetam—epilepsy syndrome	8.65e-05	0.000644	CcSEcCtD
Zafirlukast—Asthenia—Zonisamide—epilepsy syndrome	8.64e-05	0.000643	CcSEcCtD
Zafirlukast—Agranulocytosis—Topiramate—epilepsy syndrome	8.63e-05	0.000642	CcSEcCtD
Zafirlukast—Headache—Levetiracetam—epilepsy syndrome	8.6e-05	0.00064	CcSEcCtD
Zafirlukast—Angioedema—Pregabalin—epilepsy syndrome	8.56e-05	0.000637	CcSEcCtD
Zafirlukast—Hypersensitivity—Clonazepam—epilepsy syndrome	8.55e-05	0.000637	CcSEcCtD
Zafirlukast—Dizziness—Vigabatrin—epilepsy syndrome	8.54e-05	0.000636	CcSEcCtD
Zafirlukast—Pruritus—Zonisamide—epilepsy syndrome	8.52e-05	0.000634	CcSEcCtD
Zafirlukast—Hypersensitivity—Phenytoin—epilepsy syndrome	8.5e-05	0.000632	CcSEcCtD
Zafirlukast—Oedema—Valproic Acid—epilepsy syndrome	8.46e-05	0.000629	CcSEcCtD
Zafirlukast—Urticaria—Lamotrigine—epilepsy syndrome	8.45e-05	0.000629	CcSEcCtD
Zafirlukast—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	8.45e-05	0.000629	CcSEcCtD
Zafirlukast—Malaise—Pregabalin—epilepsy syndrome	8.45e-05	0.000629	CcSEcCtD
Zafirlukast—Nausea—Propofol—epilepsy syndrome	8.44e-05	0.000628	CcSEcCtD
Zafirlukast—Vomiting—Fosphenytoin—epilepsy syndrome	8.43e-05	0.000627	CcSEcCtD
Zafirlukast—Diarrhoea—Felbamate—epilepsy syndrome	8.42e-05	0.000627	CcSEcCtD
Zafirlukast—Body temperature increased—Lamotrigine—epilepsy syndrome	8.41e-05	0.000626	CcSEcCtD
Zafirlukast—Abdominal pain—Lamotrigine—epilepsy syndrome	8.41e-05	0.000626	CcSEcCtD
Zafirlukast—Dizziness—Diazepam—epilepsy syndrome	8.41e-05	0.000626	CcSEcCtD
Zafirlukast—Infection—Valproic Acid—epilepsy syndrome	8.4e-05	0.000625	CcSEcCtD
Zafirlukast—Rash—Fosphenytoin—epilepsy syndrome	8.36e-05	0.000622	CcSEcCtD
Zafirlukast—Dermatitis—Fosphenytoin—epilepsy syndrome	8.35e-05	0.000621	CcSEcCtD
Zafirlukast—Haemoglobin—Topiramate—epilepsy syndrome	8.34e-05	0.000621	CcSEcCtD
Zafirlukast—Asthenia—Clonazepam—epilepsy syndrome	8.33e-05	0.00062	CcSEcCtD
Zafirlukast—Back pain—Gabapentin—epilepsy syndrome	8.31e-05	0.000618	CcSEcCtD
Zafirlukast—Headache—Fosphenytoin—epilepsy syndrome	8.3e-05	0.000618	CcSEcCtD
Zafirlukast—Hepatitis—Topiramate—epilepsy syndrome	8.3e-05	0.000618	CcSEcCtD
Zafirlukast—Haemorrhage—Topiramate—epilepsy syndrome	8.3e-05	0.000618	CcSEcCtD
Zafirlukast—Thrombocytopenia—Valproic Acid—epilepsy syndrome	8.28e-05	0.000616	CcSEcCtD
Zafirlukast—Asthenia—Phenytoin—epilepsy syndrome	8.28e-05	0.000616	CcSEcCtD
Zafirlukast—Nausea—Midazolam—epilepsy syndrome	8.26e-05	0.000615	CcSEcCtD
Zafirlukast—Hypoaesthesia—Topiramate—epilepsy syndrome	8.26e-05	0.000615	CcSEcCtD
Zafirlukast—Diarrhoea—Zonisamide—epilepsy syndrome	8.24e-05	0.000613	CcSEcCtD
Zafirlukast—Asthenia—Oxcarbazepine—epilepsy syndrome	8.23e-05	0.000613	CcSEcCtD
Zafirlukast—Pruritus—Clonazepam—epilepsy syndrome	8.22e-05	0.000611	CcSEcCtD
Zafirlukast—Vomiting—Vigabatrin—epilepsy syndrome	8.21e-05	0.000611	CcSEcCtD
Zafirlukast—Pruritus—Phenytoin—epilepsy syndrome	8.16e-05	0.000607	CcSEcCtD
Zafirlukast—Nausea—Levetiracetam—epilepsy syndrome	8.16e-05	0.000607	CcSEcCtD
Zafirlukast—Rash—Vigabatrin—epilepsy syndrome	8.14e-05	0.000606	CcSEcCtD
Zafirlukast—Dizziness—Felbamate—epilepsy syndrome	8.14e-05	0.000606	CcSEcCtD
Zafirlukast—Dermatitis—Vigabatrin—epilepsy syndrome	8.14e-05	0.000606	CcSEcCtD
Zafirlukast—Pruritus—Oxcarbazepine—epilepsy syndrome	8.12e-05	0.000604	CcSEcCtD
Zafirlukast—Hypersensitivity—Carbamazepine—epilepsy syndrome	8.11e-05	0.000604	CcSEcCtD
Zafirlukast—Headache—Vigabatrin—epilepsy syndrome	8.09e-05	0.000602	CcSEcCtD
Zafirlukast—Vomiting—Diazepam—epilepsy syndrome	8.09e-05	0.000602	CcSEcCtD
Zafirlukast—Rash—Diazepam—epilepsy syndrome	8.02e-05	0.000597	CcSEcCtD
Zafirlukast—Dermatitis—Diazepam—epilepsy syndrome	8.01e-05	0.000596	CcSEcCtD
Zafirlukast—Myalgia—Pregabalin—epilepsy syndrome	7.97e-05	0.000593	CcSEcCtD
Zafirlukast—Arthralgia—Pregabalin—epilepsy syndrome	7.97e-05	0.000593	CcSEcCtD
Zafirlukast—Ill-defined disorder—Gabapentin—epilepsy syndrome	7.97e-05	0.000593	CcSEcCtD
Zafirlukast—Dizziness—Zonisamide—epilepsy syndrome	7.97e-05	0.000593	CcSEcCtD
Zafirlukast—Headache—Diazepam—epilepsy syndrome	7.97e-05	0.000593	CcSEcCtD
Zafirlukast—Diarrhoea—Clonazepam—epilepsy syndrome	7.94e-05	0.000591	CcSEcCtD
Zafirlukast—Asthenia—Carbamazepine—epilepsy syndrome	7.9e-05	0.000588	CcSEcCtD
Zafirlukast—Diarrhoea—Phenytoin—epilepsy syndrome	7.89e-05	0.000587	CcSEcCtD
Zafirlukast—Discomfort—Pregabalin—epilepsy syndrome	7.88e-05	0.000586	CcSEcCtD
Zafirlukast—Nausea—Fosphenytoin—epilepsy syndrome	7.87e-05	0.000586	CcSEcCtD
Zafirlukast—Diarrhoea—Oxcarbazepine—epilepsy syndrome	7.85e-05	0.000584	CcSEcCtD
Zafirlukast—Angioedema—Gabapentin—epilepsy syndrome	7.85e-05	0.000584	CcSEcCtD
Zafirlukast—Hypersensitivity—Lamotrigine—epilepsy syndrome	7.84e-05	0.000583	CcSEcCtD
Zafirlukast—Vomiting—Felbamate—epilepsy syndrome	7.83e-05	0.000582	CcSEcCtD
Zafirlukast—Pruritus—Carbamazepine—epilepsy syndrome	7.79e-05	0.00058	CcSEcCtD
Zafirlukast—Rash—Felbamate—epilepsy syndrome	7.76e-05	0.000578	CcSEcCtD
Zafirlukast—Dermatitis—Felbamate—epilepsy syndrome	7.75e-05	0.000577	CcSEcCtD
Zafirlukast—Malaise—Gabapentin—epilepsy syndrome	7.74e-05	0.000576	CcSEcCtD
Zafirlukast—Headache—Felbamate—epilepsy syndrome	7.71e-05	0.000574	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	7.7e-05	0.000573	CcSEcCtD
Zafirlukast—Dizziness—Clonazepam—epilepsy syndrome	7.68e-05	0.000571	CcSEcCtD
Zafirlukast—Nausea—Vigabatrin—epilepsy syndrome	7.67e-05	0.000571	CcSEcCtD
Zafirlukast—Vomiting—Zonisamide—epilepsy syndrome	7.66e-05	0.00057	CcSEcCtD
Zafirlukast—Insomnia—Valproic Acid—epilepsy syndrome	7.65e-05	0.000569	CcSEcCtD
Zafirlukast—Oedema—Pregabalin—epilepsy syndrome	7.64e-05	0.000569	CcSEcCtD
Zafirlukast—Asthenia—Lamotrigine—epilepsy syndrome	7.63e-05	0.000568	CcSEcCtD
Zafirlukast—Dizziness—Phenytoin—epilepsy syndrome	7.63e-05	0.000568	CcSEcCtD
Zafirlukast—Rash—Zonisamide—epilepsy syndrome	7.6e-05	0.000565	CcSEcCtD
Zafirlukast—Infection—Pregabalin—epilepsy syndrome	7.59e-05	0.000565	CcSEcCtD
Zafirlukast—Dermatitis—Zonisamide—epilepsy syndrome	7.59e-05	0.000565	CcSEcCtD
Zafirlukast—Dizziness—Oxcarbazepine—epilepsy syndrome	7.59e-05	0.000565	CcSEcCtD
Zafirlukast—Nausea—Diazepam—epilepsy syndrome	7.55e-05	0.000562	CcSEcCtD
Zafirlukast—Headache—Zonisamide—epilepsy syndrome	7.55e-05	0.000562	CcSEcCtD
Zafirlukast—Diarrhoea—Carbamazepine—epilepsy syndrome	7.53e-05	0.000561	CcSEcCtD
Zafirlukast—Pruritus—Lamotrigine—epilepsy syndrome	7.53e-05	0.00056	CcSEcCtD
Zafirlukast—Thrombocytopenia—Pregabalin—epilepsy syndrome	7.48e-05	0.000557	CcSEcCtD
Zafirlukast—Dyspepsia—Valproic Acid—epilepsy syndrome	7.44e-05	0.000554	CcSEcCtD
Zafirlukast—Vomiting—Clonazepam—epilepsy syndrome	7.38e-05	0.000549	CcSEcCtD
Zafirlukast—Vomiting—Phenytoin—epilepsy syndrome	7.33e-05	0.000546	CcSEcCtD
Zafirlukast—Rash—Clonazepam—epilepsy syndrome	7.32e-05	0.000545	CcSEcCtD
Zafirlukast—Dermatitis—Clonazepam—epilepsy syndrome	7.31e-05	0.000544	CcSEcCtD
Zafirlukast—Arthralgia—Gabapentin—epilepsy syndrome	7.31e-05	0.000544	CcSEcCtD
Zafirlukast—Myalgia—Gabapentin—epilepsy syndrome	7.31e-05	0.000544	CcSEcCtD
Zafirlukast—Nausea—Felbamate—epilepsy syndrome	7.31e-05	0.000544	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	7.3e-05	0.000543	CcSEcCtD
Zafirlukast—Vomiting—Oxcarbazepine—epilepsy syndrome	7.29e-05	0.000543	CcSEcCtD
Zafirlukast—Fatigue—Valproic Acid—epilepsy syndrome	7.29e-05	0.000542	CcSEcCtD
Zafirlukast—Dizziness—Carbamazepine—epilepsy syndrome	7.28e-05	0.000542	CcSEcCtD
Zafirlukast—Diarrhoea—Lamotrigine—epilepsy syndrome	7.28e-05	0.000542	CcSEcCtD
Zafirlukast—Headache—Clonazepam—epilepsy syndrome	7.27e-05	0.000541	CcSEcCtD
Zafirlukast—Rash—Phenytoin—epilepsy syndrome	7.27e-05	0.000541	CcSEcCtD
Zafirlukast—Dermatitis—Phenytoin—epilepsy syndrome	7.27e-05	0.000541	CcSEcCtD
Zafirlukast—Rash—Oxcarbazepine—epilepsy syndrome	7.23e-05	0.000538	CcSEcCtD
Zafirlukast—Pain—Valproic Acid—epilepsy syndrome	7.23e-05	0.000538	CcSEcCtD
Zafirlukast—Dermatitis—Oxcarbazepine—epilepsy syndrome	7.23e-05	0.000538	CcSEcCtD
Zafirlukast—Headache—Phenytoin—epilepsy syndrome	7.23e-05	0.000538	CcSEcCtD
Zafirlukast—Discomfort—Gabapentin—epilepsy syndrome	7.22e-05	0.000538	CcSEcCtD
Zafirlukast—Headache—Oxcarbazepine—epilepsy syndrome	7.19e-05	0.000535	CcSEcCtD
Zafirlukast—Nausea—Zonisamide—epilepsy syndrome	7.16e-05	0.000533	CcSEcCtD
Zafirlukast—Dizziness—Lamotrigine—epilepsy syndrome	7.04e-05	0.000524	CcSEcCtD
Zafirlukast—Oedema—Gabapentin—epilepsy syndrome	7.01e-05	0.000522	CcSEcCtD
Zafirlukast—Vomiting—Carbamazepine—epilepsy syndrome	7e-05	0.000521	CcSEcCtD
Zafirlukast—Back pain—Topiramate—epilepsy syndrome	6.99e-05	0.00052	CcSEcCtD
Zafirlukast—Feeling abnormal—Valproic Acid—epilepsy syndrome	6.97e-05	0.000519	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	6.96e-05	0.000518	CcSEcCtD
Zafirlukast—Infection—Gabapentin—epilepsy syndrome	6.96e-05	0.000518	CcSEcCtD
Zafirlukast—Rash—Carbamazepine—epilepsy syndrome	6.94e-05	0.000517	CcSEcCtD
Zafirlukast—Dermatitis—Carbamazepine—epilepsy syndrome	6.94e-05	0.000516	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	6.91e-05	0.000515	CcSEcCtD
Zafirlukast—Insomnia—Pregabalin—epilepsy syndrome	6.91e-05	0.000515	CcSEcCtD
Zafirlukast—Nausea—Clonazepam—epilepsy syndrome	6.9e-05	0.000513	CcSEcCtD
Zafirlukast—Headache—Carbamazepine—epilepsy syndrome	6.9e-05	0.000513	CcSEcCtD
Zafirlukast—Thrombocytopenia—Gabapentin—epilepsy syndrome	6.86e-05	0.000511	CcSEcCtD
Zafirlukast—Nausea—Phenytoin—epilepsy syndrome	6.85e-05	0.00051	CcSEcCtD
Zafirlukast—Nausea—Oxcarbazepine—epilepsy syndrome	6.81e-05	0.000507	CcSEcCtD
Zafirlukast—Vomiting—Lamotrigine—epilepsy syndrome	6.77e-05	0.000503	CcSEcCtD
Zafirlukast—Urticaria—Valproic Acid—epilepsy syndrome	6.72e-05	0.0005	CcSEcCtD
Zafirlukast—Rash—Lamotrigine—epilepsy syndrome	6.71e-05	0.000499	CcSEcCtD
Zafirlukast—Ill-defined disorder—Topiramate—epilepsy syndrome	6.7e-05	0.000499	CcSEcCtD
Zafirlukast—Dermatitis—Lamotrigine—epilepsy syndrome	6.7e-05	0.000499	CcSEcCtD
Zafirlukast—Abdominal pain—Valproic Acid—epilepsy syndrome	6.68e-05	0.000497	CcSEcCtD
Zafirlukast—Body temperature increased—Valproic Acid—epilepsy syndrome	6.68e-05	0.000497	CcSEcCtD
Zafirlukast—Headache—Lamotrigine—epilepsy syndrome	6.67e-05	0.000496	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	6.6e-05	0.000491	CcSEcCtD
Zafirlukast—Fatigue—Pregabalin—epilepsy syndrome	6.59e-05	0.00049	CcSEcCtD
Zafirlukast—Nausea—Carbamazepine—epilepsy syndrome	6.54e-05	0.000487	CcSEcCtD
Zafirlukast—Pain—Pregabalin—epilepsy syndrome	6.54e-05	0.000486	CcSEcCtD
Zafirlukast—Malaise—Topiramate—epilepsy syndrome	6.52e-05	0.000485	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	6.39e-05	0.000475	CcSEcCtD
Zafirlukast—Insomnia—Gabapentin—epilepsy syndrome	6.34e-05	0.000472	CcSEcCtD
Zafirlukast—Nausea—Lamotrigine—epilepsy syndrome	6.32e-05	0.00047	CcSEcCtD
Zafirlukast—Feeling abnormal—Pregabalin—epilepsy syndrome	6.3e-05	0.000469	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Pregabalin—epilepsy syndrome	6.25e-05	0.000465	CcSEcCtD
Zafirlukast—Hypersensitivity—Valproic Acid—epilepsy syndrome	6.23e-05	0.000464	CcSEcCtD
Zafirlukast—Dyspepsia—Gabapentin—epilepsy syndrome	6.17e-05	0.000459	CcSEcCtD
Zafirlukast—Arthralgia—Topiramate—epilepsy syndrome	6.15e-05	0.000458	CcSEcCtD
Zafirlukast—Myalgia—Topiramate—epilepsy syndrome	6.15e-05	0.000458	CcSEcCtD
Zafirlukast—Discomfort—Topiramate—epilepsy syndrome	6.08e-05	0.000452	CcSEcCtD
Zafirlukast—Urticaria—Pregabalin—epilepsy syndrome	6.07e-05	0.000452	CcSEcCtD
Zafirlukast—Asthenia—Valproic Acid—epilepsy syndrome	6.07e-05	0.000451	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	6.05e-05	0.00045	CcSEcCtD
Zafirlukast—Fatigue—Gabapentin—epilepsy syndrome	6.04e-05	0.00045	CcSEcCtD
Zafirlukast—Abdominal pain—Pregabalin—epilepsy syndrome	6.04e-05	0.00045	CcSEcCtD
Zafirlukast—Body temperature increased—Pregabalin—epilepsy syndrome	6.04e-05	0.00045	CcSEcCtD
Zafirlukast—Pain—Gabapentin—epilepsy syndrome	5.99e-05	0.000446	CcSEcCtD
Zafirlukast—Pruritus—Valproic Acid—epilepsy syndrome	5.98e-05	0.000445	CcSEcCtD
Zafirlukast—Oedema—Topiramate—epilepsy syndrome	5.9e-05	0.000439	CcSEcCtD
Zafirlukast—Infection—Topiramate—epilepsy syndrome	5.86e-05	0.000436	CcSEcCtD
Zafirlukast—Diarrhoea—Valproic Acid—epilepsy syndrome	5.79e-05	0.000431	CcSEcCtD
Zafirlukast—Feeling abnormal—Gabapentin—epilepsy syndrome	5.78e-05	0.00043	CcSEcCtD
Zafirlukast—Thrombocytopenia—Topiramate—epilepsy syndrome	5.77e-05	0.00043	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Gabapentin—epilepsy syndrome	5.73e-05	0.000427	CcSEcCtD
Zafirlukast—Hypersensitivity—Pregabalin—epilepsy syndrome	5.63e-05	0.000419	CcSEcCtD
Zafirlukast—Dizziness—Valproic Acid—epilepsy syndrome	5.59e-05	0.000416	CcSEcCtD
Zafirlukast—Urticaria—Gabapentin—epilepsy syndrome	5.57e-05	0.000414	CcSEcCtD
Zafirlukast—Abdominal pain—Gabapentin—epilepsy syndrome	5.54e-05	0.000412	CcSEcCtD
Zafirlukast—Body temperature increased—Gabapentin—epilepsy syndrome	5.54e-05	0.000412	CcSEcCtD
Zafirlukast—Asthenia—Pregabalin—epilepsy syndrome	5.48e-05	0.000408	CcSEcCtD
Zafirlukast—Pruritus—Pregabalin—epilepsy syndrome	5.41e-05	0.000402	CcSEcCtD
Zafirlukast—Vomiting—Valproic Acid—epilepsy syndrome	5.38e-05	0.0004	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	5.37e-05	0.0004	CcSEcCtD
Zafirlukast—Insomnia—Topiramate—epilepsy syndrome	5.33e-05	0.000397	CcSEcCtD
Zafirlukast—Rash—Valproic Acid—epilepsy syndrome	5.33e-05	0.000397	CcSEcCtD
Zafirlukast—Dermatitis—Valproic Acid—epilepsy syndrome	5.33e-05	0.000396	CcSEcCtD
Zafirlukast—Headache—Valproic Acid—epilepsy syndrome	5.3e-05	0.000394	CcSEcCtD
Zafirlukast—Diarrhoea—Pregabalin—epilepsy syndrome	5.23e-05	0.000389	CcSEcCtD
Zafirlukast—Dyspepsia—Topiramate—epilepsy syndrome	5.19e-05	0.000386	CcSEcCtD
Zafirlukast—Hypersensitivity—Gabapentin—epilepsy syndrome	5.16e-05	0.000384	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Topiramate—epilepsy syndrome	5.09e-05	0.000379	CcSEcCtD
Zafirlukast—Fatigue—Topiramate—epilepsy syndrome	5.08e-05	0.000378	CcSEcCtD
Zafirlukast—Dizziness—Pregabalin—epilepsy syndrome	5.05e-05	0.000376	CcSEcCtD
Zafirlukast—Pain—Topiramate—epilepsy syndrome	5.04e-05	0.000375	CcSEcCtD
Zafirlukast—Asthenia—Gabapentin—epilepsy syndrome	5.03e-05	0.000374	CcSEcCtD
Zafirlukast—Nausea—Valproic Acid—epilepsy syndrome	5.02e-05	0.000374	CcSEcCtD
Zafirlukast—Pruritus—Gabapentin—epilepsy syndrome	4.96e-05	0.000369	CcSEcCtD
Zafirlukast—Vomiting—Pregabalin—epilepsy syndrome	4.86e-05	0.000362	CcSEcCtD
Zafirlukast—Feeling abnormal—Topiramate—epilepsy syndrome	4.86e-05	0.000362	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Topiramate—epilepsy syndrome	4.82e-05	0.000359	CcSEcCtD
Zafirlukast—Rash—Pregabalin—epilepsy syndrome	4.82e-05	0.000359	CcSEcCtD
Zafirlukast—Dermatitis—Pregabalin—epilepsy syndrome	4.82e-05	0.000358	CcSEcCtD
Zafirlukast—Diarrhoea—Gabapentin—epilepsy syndrome	4.8e-05	0.000357	CcSEcCtD
Zafirlukast—Headache—Pregabalin—epilepsy syndrome	4.79e-05	0.000356	CcSEcCtD
Zafirlukast—Urticaria—Topiramate—epilepsy syndrome	4.68e-05	0.000349	CcSEcCtD
Zafirlukast—Abdominal pain—Topiramate—epilepsy syndrome	4.66e-05	0.000347	CcSEcCtD
Zafirlukast—Body temperature increased—Topiramate—epilepsy syndrome	4.66e-05	0.000347	CcSEcCtD
Zafirlukast—Dizziness—Gabapentin—epilepsy syndrome	4.64e-05	0.000345	CcSEcCtD
Zafirlukast—Nausea—Pregabalin—epilepsy syndrome	4.54e-05	0.000338	CcSEcCtD
Zafirlukast—Vomiting—Gabapentin—epilepsy syndrome	4.46e-05	0.000332	CcSEcCtD
Zafirlukast—Rash—Gabapentin—epilepsy syndrome	4.42e-05	0.000329	CcSEcCtD
Zafirlukast—Dermatitis—Gabapentin—epilepsy syndrome	4.42e-05	0.000329	CcSEcCtD
Zafirlukast—Headache—Gabapentin—epilepsy syndrome	4.39e-05	0.000327	CcSEcCtD
Zafirlukast—Hypersensitivity—Topiramate—epilepsy syndrome	4.34e-05	0.000323	CcSEcCtD
Zafirlukast—Asthenia—Topiramate—epilepsy syndrome	4.23e-05	0.000315	CcSEcCtD
Zafirlukast—Pruritus—Topiramate—epilepsy syndrome	4.17e-05	0.00031	CcSEcCtD
Zafirlukast—Nausea—Gabapentin—epilepsy syndrome	4.16e-05	0.00031	CcSEcCtD
Zafirlukast—Diarrhoea—Topiramate—epilepsy syndrome	4.03e-05	0.0003	CcSEcCtD
Zafirlukast—Dizziness—Topiramate—epilepsy syndrome	3.9e-05	0.00029	CcSEcCtD
Zafirlukast—Vomiting—Topiramate—epilepsy syndrome	3.75e-05	0.000279	CcSEcCtD
Zafirlukast—Rash—Topiramate—epilepsy syndrome	3.72e-05	0.000277	CcSEcCtD
Zafirlukast—Dermatitis—Topiramate—epilepsy syndrome	3.71e-05	0.000276	CcSEcCtD
Zafirlukast—Headache—Topiramate—epilepsy syndrome	3.69e-05	0.000275	CcSEcCtD
Zafirlukast—Nausea—Topiramate—epilepsy syndrome	3.5e-05	0.000261	CcSEcCtD
Zafirlukast—CYP2D6—Metabolism—ADSL—epilepsy syndrome	5.62e-06	7.69e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—SLC2A1—epilepsy syndrome	5.61e-06	7.69e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—COX3—epilepsy syndrome	5.59e-06	7.65e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—ADSL—epilepsy syndrome	5.57e-06	7.62e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PLCB1—epilepsy syndrome	5.55e-06	7.61e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—TH—epilepsy syndrome	5.53e-06	7.58e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—GLUL—epilepsy syndrome	5.51e-06	7.54e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—TXNRD1—epilepsy syndrome	5.5e-06	7.53e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ASAH1—epilepsy syndrome	5.49e-06	7.51e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—GLUL—epilepsy syndrome	5.46e-06	7.48e-05	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—AKT1—epilepsy syndrome	5.43e-06	7.44e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—CHRM3—epilepsy syndrome	5.41e-06	7.41e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—KCNJ11—epilepsy syndrome	5.41e-06	7.41e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CACNA1D—epilepsy syndrome	5.41e-06	7.4e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—SLC2A1—epilepsy syndrome	5.39e-06	7.39e-05	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CASP3—epilepsy syndrome	5.38e-06	7.37e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CACNA1D—epilepsy syndrome	5.36e-06	7.34e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—STXBP1—epilepsy syndrome	5.34e-06	7.31e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—AQP1—epilepsy syndrome	5.34e-06	7.31e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PLCB1—epilepsy syndrome	5.34e-06	7.31e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—TH—epilepsy syndrome	5.32e-06	7.28e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PFKL—epilepsy syndrome	5.3e-06	7.25e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	5.3e-06	7.25e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	5.3e-06	7.25e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	5.3e-06	7.25e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	5.3e-06	7.25e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	5.23e-06	7.17e-05	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—JUN—epilepsy syndrome	5.23e-06	7.16e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—NT5E—epilepsy syndrome	5.2e-06	7.12e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ALAD—epilepsy syndrome	5.2e-06	7.12e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	5.13e-06	7.02e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—ABCG2—epilepsy syndrome	5.1e-06	6.98e-05	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—MMP9—epilepsy syndrome	5.09e-06	6.97e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	5.06e-06	6.92e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	5.04e-06	6.9e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	5.01e-06	6.86e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—CYP2C19—epilepsy syndrome	4.97e-06	6.81e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CACNA1A—epilepsy syndrome	4.96e-06	6.8e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ALDH7A1—epilepsy syndrome	4.96e-06	6.8e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—CYP11A1—epilepsy syndrome	4.94e-06	6.76e-05	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—AKT1—epilepsy syndrome	4.93e-06	6.76e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	4.93e-06	6.76e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—AQP1—epilepsy syndrome	4.91e-06	6.72e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—AQP1—epilepsy syndrome	4.87e-06	6.66e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ST3GAL3—epilepsy syndrome	4.86e-06	6.65e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—UPB1—epilepsy syndrome	4.84e-06	6.63e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—NEU1—epilepsy syndrome	4.84e-06	6.63e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ATIC—epilepsy syndrome	4.84e-06	6.63e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—CHRM3—epilepsy syndrome	4.83e-06	6.61e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—KCNJ11—epilepsy syndrome	4.83e-06	6.61e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ADSL—epilepsy syndrome	4.76e-06	6.52e-05	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—SRC—epilepsy syndrome	4.69e-06	6.42e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	4.67e-06	6.4e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—GLUL—epilepsy syndrome	4.67e-06	6.39e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	4.66e-06	6.39e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—HMOX1—epilepsy syndrome	4.62e-06	6.32e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CACNA1D—epilepsy syndrome	4.58e-06	6.27e-05	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—VEGFA—epilepsy syndrome	4.57e-06	6.26e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—CAT—epilepsy syndrome	4.56e-06	6.24e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	4.5e-06	6.17e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—GBE1—epilepsy syndrome	4.5e-06	6.17e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	4.49e-06	6.16e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—CYP2D6—epilepsy syndrome	4.46e-06	6.1e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	4.44e-06	6.08e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	4.44e-06	6.08e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—HMOX1—epilepsy syndrome	4.44e-06	6.08e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—ABCB1—epilepsy syndrome	4.43e-06	6.07e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—ABCG2—epilepsy syndrome	4.41e-06	6.04e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	4.4e-06	6.03e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	4.4e-06	6.03e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	4.4e-06	6.03e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—CAT—epilepsy syndrome	4.38e-06	6e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—CYP2C19—epilepsy syndrome	4.3e-06	5.88e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—TXNRD1—epilepsy syndrome	4.28e-06	5.87e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—CYP11A1—epilepsy syndrome	4.27e-06	5.85e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—ABCB1—epilepsy syndrome	4.26e-06	5.83e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—ADRA2A—epilepsy syndrome	4.24e-06	5.81e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	4.24e-06	5.8e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	4.23e-06	5.8e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—BCHE—epilepsy syndrome	4.23e-06	5.79e-05	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—AKT1—epilepsy syndrome	4.21e-06	5.76e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—AQP1—epilepsy syndrome	4.16e-06	5.69e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—GPX1—epilepsy syndrome	4.12e-06	5.64e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	4.12e-06	5.64e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	4.1e-06	5.61e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—SLC2A1—epilepsy syndrome	4.03e-06	5.52e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	4.02e-06	5.5e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ALAD—epilepsy syndrome	4.01e-06	5.5e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—NT5E—epilepsy syndrome	4.01e-06	5.5e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	3.99e-06	5.47e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PLCB1—epilepsy syndrome	3.99e-06	5.46e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—TH—epilepsy syndrome	3.97e-06	5.44e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—GPX1—epilepsy syndrome	3.96e-06	5.42e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—ABCG2—epilepsy syndrome	3.93e-06	5.39e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	3.86e-06	5.29e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—CYP2D6—epilepsy syndrome	3.85e-06	5.28e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	3.83e-06	5.24e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	3.83e-06	5.24e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—CYP11A1—epilepsy syndrome	3.81e-06	5.22e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.78e-06	5.18e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CHRM3—epilepsy syndrome	3.76e-06	5.15e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—KCNJ11—epilepsy syndrome	3.76e-06	5.15e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	3.75e-06	5.13e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ADSL—epilepsy syndrome	3.67e-06	5.03e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—ADRA2A—epilepsy syndrome	3.67e-06	5.02e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—BCHE—epilepsy syndrome	3.65e-06	5e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	3.62e-06	4.96e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—AGT—epilepsy syndrome	3.61e-06	4.95e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—GLUL—epilepsy syndrome	3.6e-06	4.93e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	3.59e-06	4.91e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—APOE—epilepsy syndrome	3.54e-06	4.85e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	3.53e-06	4.84e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	3.53e-06	4.83e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	3.5e-06	4.8e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	3.5e-06	4.8e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	3.5e-06	4.79e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—SLC2A1—epilepsy syndrome	3.48e-06	4.77e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	3.47e-06	4.76e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—AGT—epilepsy syndrome	3.47e-06	4.75e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.45e-06	4.72e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	3.45e-06	4.72e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PLCB1—epilepsy syndrome	3.45e-06	4.72e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	3.44e-06	4.71e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—TH—epilepsy syndrome	3.43e-06	4.7e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	3.43e-06	4.7e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—APOE—epilepsy syndrome	3.4e-06	4.66e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.38e-06	4.63e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—HMOX1—epilepsy syndrome	3.32e-06	4.54e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	3.31e-06	4.53e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	3.27e-06	4.48e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—CAT—epilepsy syndrome	3.27e-06	4.48e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—BCHE—epilepsy syndrome	3.26e-06	4.46e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—AQP1—epilepsy syndrome	3.21e-06	4.4e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—ABCB1—epilepsy syndrome	3.18e-06	4.36e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	3.14e-06	4.31e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	3.14e-06	4.29e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	3.11e-06	4.26e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	3.08e-06	4.21e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	3.07e-06	4.2e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—TH—epilepsy syndrome	3.07e-06	4.2e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—POMC—epilepsy syndrome	3.04e-06	4.17e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.02e-06	4.13e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	3.01e-06	4.12e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—BCHE—epilepsy syndrome	3e-06	4.11e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	2.99e-06	4.09e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	2.99e-06	4.09e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—BCHE—epilepsy syndrome	2.97e-06	4.07e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	2.97e-06	4.07e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—GPX1—epilepsy syndrome	2.96e-06	4.05e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.95e-06	4.04e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—POMC—epilepsy syndrome	2.92e-06	4e-05	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—AKT1—epilepsy syndrome	2.91e-06	3.99e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	2.9e-06	3.97e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	2.9e-06	3.97e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—HMOX1—epilepsy syndrome	2.87e-06	3.93e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	2.86e-06	3.92e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	2.84e-06	3.88e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	2.83e-06	3.87e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—CAT—epilepsy syndrome	2.83e-06	3.87e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—TH—epilepsy syndrome	2.82e-06	3.86e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	2.8e-06	3.84e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—TH—epilepsy syndrome	2.79e-06	3.83e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—ALB—epilepsy syndrome	2.77e-06	3.8e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.75e-06	3.77e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—ABCB1—epilepsy syndrome	2.75e-06	3.77e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.69e-06	3.68e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	2.68e-06	3.67e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—ALB—epilepsy syndrome	2.66e-06	3.65e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—AGT—epilepsy syndrome	2.59e-06	3.55e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	2.56e-06	3.5e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—GPX1—epilepsy syndrome	2.56e-06	3.5e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	2.55e-06	3.49e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—APOE—epilepsy syndrome	2.54e-06	3.48e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—BCHE—epilepsy syndrome	2.54e-06	3.48e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—CAT—epilepsy syndrome	2.52e-06	3.46e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	2.46e-06	3.36e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PTGS2—epilepsy syndrome	2.43e-06	3.32e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	2.42e-06	3.32e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	2.4e-06	3.28e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—TH—epilepsy syndrome	2.39e-06	3.27e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	2.37e-06	3.24e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	2.35e-06	3.22e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.35e-06	3.22e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	2.33e-06	3.19e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PTGS2—epilepsy syndrome	2.33e-06	3.19e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CAT—epilepsy syndrome	2.32e-06	3.18e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	2.31e-06	3.16e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CAT—epilepsy syndrome	2.3e-06	3.15e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	2.29e-06	3.14e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—GPX1—epilepsy syndrome	2.28e-06	3.13e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	2.26e-06	3.09e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—AGT—epilepsy syndrome	2.24e-06	3.07e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	2.24e-06	3.07e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—APOE—epilepsy syndrome	2.2e-06	3.01e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—POMC—epilepsy syndrome	2.18e-06	2.99e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—GPX1—epilepsy syndrome	2.1e-06	2.88e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—GPX1—epilepsy syndrome	2.08e-06	2.85e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	2.07e-06	2.83e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—AGT—epilepsy syndrome	2e-06	2.74e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	1.99e-06	2.73e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—ALB—epilepsy syndrome	1.99e-06	2.73e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	1.97e-06	2.7e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CAT—epilepsy syndrome	1.97e-06	2.69e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—APOE—epilepsy syndrome	1.96e-06	2.69e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—BCHE—epilepsy syndrome	1.96e-06	2.68e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	1.91e-06	2.62e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—POMC—epilepsy syndrome	1.89e-06	2.59e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	1.87e-06	2.56e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	1.85e-06	2.53e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—TH—epilepsy syndrome	1.84e-06	2.52e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—AGT—epilepsy syndrome	1.84e-06	2.52e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—AGT—epilepsy syndrome	1.83e-06	2.5e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—APOE—epilepsy syndrome	1.8e-06	2.47e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—APOE—epilepsy syndrome	1.79e-06	2.45e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—GPX1—epilepsy syndrome	1.78e-06	2.44e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PTGS2—epilepsy syndrome	1.74e-06	2.39e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—ALB—epilepsy syndrome	1.72e-06	2.36e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—POMC—epilepsy syndrome	1.68e-06	2.31e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—AGT—epilepsy syndrome	1.56e-06	2.14e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—POMC—epilepsy syndrome	1.55e-06	2.12e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.54e-06	2.11e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—POMC—epilepsy syndrome	1.54e-06	2.1e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—ALB—epilepsy syndrome	1.54e-06	2.1e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—APOE—epilepsy syndrome	1.53e-06	2.09e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.52e-06	2.08e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PTGS2—epilepsy syndrome	1.51e-06	2.06e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.48e-06	2.02e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—ALB—epilepsy syndrome	1.41e-06	1.93e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—ALB—epilepsy syndrome	1.4e-06	1.92e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1.37e-06	1.88e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	1.34e-06	1.84e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—POMC—epilepsy syndrome	1.31e-06	1.8e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	1.24e-06	1.69e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	1.23e-06	1.68e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—AKT1—epilepsy syndrome	1.22e-06	1.67e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.2e-06	1.65e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ALB—epilepsy syndrome	1.2e-06	1.64e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—APOE—epilepsy syndrome	1.18e-06	1.62e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—AKT1—epilepsy syndrome	1.17e-06	1.6e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	1.05e-06	1.43e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.01e-06	1.39e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ALB—epilepsy syndrome	9.24e-07	1.27e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—AKT1—epilepsy syndrome	8.75e-07	1.2e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	8.08e-07	1.11e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—AKT1—epilepsy syndrome	7.57e-07	1.04e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—AKT1—epilepsy syndrome	6.75e-07	9.25e-06	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—AKT1—epilepsy syndrome	6.21e-07	8.51e-06	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—AKT1—epilepsy syndrome	6.16e-07	8.43e-06	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—AKT1—epilepsy syndrome	5.26e-07	7.21e-06	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—AKT1—epilepsy syndrome	4.06e-07	5.56e-06	CbGpPWpGaD
